BNP Paribas Financial Markets
ODT

BNP Paribas Financial Markets’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

BNP Paribas Financial Markets’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-989
Closed -$1.33K – 4453
2021
Q4 		$1.33K Buy
989
+630
+175% +$1.49K ﹤0.01% 4028
2021
Q3 		$1.04K Hold
359
– – ﹤0.01% 3869
2021
Q2 		$1.25K Sell
359
-1,726
-83% -$5.93K ﹤0.01% 3928
2021
Q1 		$7.13K Sell
2,085
-1,044
-33% -$19.7K ﹤0.01% 3852
2020
Q4 		$60.1K Sell
3,129
-38
-1% -$586 ﹤0.01% 3465
2020
Q3 		$42.5K Buy
3,167
+2,623
+482% +$74.3K ﹤0.01% 3553
2020
Q2 		$23K Sell
544
-2,462
-82% -$79.7K ﹤0.01% 3338
2020
Q1 		$83K Buy
3,006
+1,299
+76% +$37.9K ﹤0.01% 3303
2019
Q4 		$55.4K Buy
1,707
+83
+5% +$2.57K ﹤0.01% 3594
2019
Q3 		$42.3K Buy
1,624
+770
+90% +$25.8K ﹤0.01% 3578
2019
Q2 		$31.3K Sell
854
-588
-41% -$14.1K ﹤0.01% 3708
2019
Q1 		$31.9K Buy
1,442
+1,330
+1,188% +$23.3K ﹤0.01% 3748
2018
Q4 		$1.58K Sell
112
-102
-48% -$1.59K ﹤0.01% 3840
2018
Q3 		$4.15K Hold
214
– – ﹤0.01% 4127
2018
Q2 		$4.72K Sell
214
-1,015
-83% -$23.6K ﹤0.01% 4119
2018
Q1 		$26K Buy
+1,229
New +$29K ﹤0.01% 3852

Other funds holding ODT

BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

BNP Paribas Financial Markets's ODT Position: Q1 2022 in Review

BNP Paribas Financial Markets sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2022, closing a stake of 989 shares — an estimated $1.33K sold.

BNP Paribas Financial Markets first reported a position in ODT in Q1 2018 and held it in 16 quarters. The position peaked at $83K in Q1 2020. 8 funds tracked by Wall St. Rank hold ODT as of Q1 2022.

  • BNP Paribas Financial Markets reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 989 Odonate Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $1.33K.
  • BNP Paribas Financial Markets first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2018 and held it in 16 quarters.
  • BNP Paribas Financial Markets's Odonate Therapeutics, Inc. Common Stock position peaked at $83K in Q1 2020.
  • 8 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.